• Ruxolitinib in Severe, COVID-19 Patients: A Randomized Phase-II Trial

  • Sep 2 2020
  • Length: 6 mins
  • Podcast
  • 5.0 out of 5 stars (1 rating)

Ruxolitinib in Severe, COVID-19 Patients: A Randomized Phase-II Trial

Listen for free

View show details

  • Summary

  • A prospective, multi-center, single-blind, randomized controlled phase II trial assessing the efficacy and safety of ruxolitinib in hospitalized COVID-19 patients
    Show more Show less
Show more Show less

What listeners say about Ruxolitinib in Severe, COVID-19 Patients: A Randomized Phase-II Trial

Average customer ratings
Overall
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Performance
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Story
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available